CLINICAL_TRIALS
ClinicalTrials.gov record update
Expanded Access Protocol of Patisiran for Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR Amyloidosis) With Polyneuropathy
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02939820
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:31.345057+00:00
- Published At
- 2024-05-20T00:00:00+00:00
- Record Updated At
- 2024-05-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["TTR-mediated Amyloidosis", "Amyloidosis, Hereditary", "Amyloid Neuropathies, Familial", "Familial Amyloid Polyneuropathies", "Amyloid Neuropathies", "Amyloidosis, Hereditary, Transthyretin-Related"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-05-20"- protocolSection.identificationModule.nctId
"NCT02939820"- protocolSection.identificationModule.officialTitle
"Expanded Access Protocol of Patisiran for Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR Amyloidosis) With Polyneuropathy"- protocolSection.statusModule.overallStatus
"APPROVED_FOR_MARKETING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.